Agilon Health, Inc. (AGL) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 6 Buy, 17 Hold, 2 Sell.
The consensus price target is $3.51 (low: $1.10, high: $6.50), representing a downside of 84.5% from the current price $22.68.
Analysts estimate Earnings Per Share (EPS) of $-0.56 and revenue of $6.06B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.63 vs est $-0.56 (missed -13.4%). 2025: actual $-24.50 vs est $-0.78 (missed -3035.6%). Analyst accuracy: 46%.
AGL Stock — 12-Month Price Forecast
$3.51
▼ -84.52% Downside
Average Price Target
Based on 25 Wall Street analysts offering 12-month price targets for Agilon Health, Inc., the average price target is $3.51, with a high forecast of $6.50, and a low forecast of $1.10.
The average price target represents a -84.52% change from the last price of $22.68.
Highest Price Target
$6.50
Average Price Target
$3.51
Lowest Price Target
$1.10
AGL Analyst Ratings
Hold
Based on 25 analysts giving stock ratings to Agilon Health, Inc. in the past 3 months
EPS Estimates — AGL
46%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.63
vs Est –$0.56
▼ 11.8% off
2025
Actual –$24.50
vs Est –$0.78
▼ 96.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — AGL
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $6.061B
vs Est $6.057B
▲ 0.1% off
2025
Actual $5.933B
vs Est $5.824B
▲ 1.8% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
